Sign up for pamir china insights
Sign up for our China Insights bulletin
Get the latest news and views on China from our quarterly China Insights bulletin
Fill out the form below and we’ll be in touch as soon as possible.
Resource Library
Visit our Resources hub
U.S. companies see huge opportunity in China’s resurgent biotech sector
China’s booming biotech sector has become an attractive opportunity for U.S. biotech and pharma companies. But with the Biosecure Act stalled — but looming — how long will it last?
Additional restrictions on the export of rare earth elements from China increases pressure on a U.S.-Ukraine critical minerals deal
Critical elements are currently at the forefront of global geopolitics. As China and the U.S. escalate the trade war and impose export restrictions and tariffs on each other, a U.S.-Ukraine mineral deal takes on even greater importance.
Despite challenges U.S. enterprises still view China as a significant and important market
China and the U.S. offer mutually beneficial business opportunities. Despite negativity around doing business in China, American companies still view it as an important and significant market. But what’s required is an expert partner, such as Pamir Consulting, to help you navigate these challenges, mitigate risk exposure, and maximize opportunity.